Evidence map›Paper›PMID 42220478›Full record

ArticleFrontiers in immunology2026

Macrophage IL-1β turns meningeal fibroblasts into inflammatory amplifiers in pneumococcal infection.

Paul Beckenbauer, Linda Ercegovac, Greta Christensen, Pia Lagler, Sven Hammerschmidt, Stefanie Völk, Hans-Walter Pfister, Matthias Klein, Uwe Koedel, Susanne Dyckhoff-Shen

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Paul Beckenbauer *Department of Neurology, Ludwig-Maximilians-University (LMU) University Hospital, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.
Linda Ercegovac *Department of Neurology, Ludwig-Maximilians-University (LMU) University Hospital, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.
Greta ChristensenDepartment of Neurology, Ludwig-Maximilians-University (LMU) University Hospital, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.
Pia LaglerDepartment of Neurology, Ludwig-Maximilians-University (LMU) University Hospital, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.
Sven HammerschmidtDepartment of Molecular Genetics and Infection Biology, Interfaculty Institute for Genetics and Functional Genomics, Center for Functional Genomics of Microbes, University of Greifswald, Greifswald, Germany.
Stefanie VölkDepartment of Neurology, Ludwig-Maximilians-University (LMU) University Hospital, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.
Hans-Walter PfisterDepartment of Neurology, Ludwig-Maximilians-University (LMU) University Hospital, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.
Matthias KleinDepartment of Neurology, Ludwig-Maximilians-University (LMU) University Hospital, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.
Uwe KoedelDepartment of Neurology, Ludwig-Maximilians-University (LMU) University Hospital, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.
Susanne Dyckhoff-ShenDepartment of Neurology, Ludwig-Maximilians-University (LMU) University Hospital, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: In pneumococcal meningitis, a massive inflammatory reaction is triggered by the host immune system, leading to neurological damage. However, the mechanisms underlying the initiation and regulation of this response, particularly by resident cells, remain incompletely understood. Despite their strategic localization at the host-pathogen interface, the role of meningeal fibroblasts in pneumococcal meningitis remains poorly defined. This study therefore aimed to investigate their contribution to the immune response against Methods: Primary meningeal fibroblasts were exposed to Results: Meningeal fibroblasts responded to pneumococcal challenge by producing a selective set of cytokines. This activation occurred independently of Toll-like receptor signaling. In co-culture, macrophages markedly enhanced fibroblast-derived cytokine production (including IL-6, IL-8, and CCL2) in both direct and indirect systems, indicating a robust amplification of the immune response. Mechanically, this effect was driven by macrophage-derived IL-1β, which we identified as the key factor of meningeal fibroblast activation. Discussion: These findings establish an IL-1β-driven macrophage-fibroblast axis as a key driver of inflammatory amplification in pneumococcal central nervous system infection and suggest a tractable target for therapeutic intervention.

Indexed as

FibroblastsInterleukin-1betaMacrophagesMeningesMeningitis, PneumococcalStreptococcus pneumoniaeAnimalsCells, CulturedCoculture TechniquesCytokinesHumansInflammationMiceCytokinesInterleukin-1betacytokinesIL-1βIL-6macrophagesmeningeal fibroblastsneuroinflammationpneumococcal meningitisStreptococcus pneumoniae

Identifiers

PMID42220478
PMCPMC13215843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.